Zobrazeno 1 - 10
of 89
pro vyhledávání: ''
Publikováno v:
Cancer Biomarkers. 32:271-279
This paper aimed at investigating AS1 expression in prostate cancer (PCa) and its effects on the proliferation and invasion of prostate cancer cells (PCCs). The prostate tissues and the matched adjacent normal prostate tissues excised and preserved d
Autor:
Bulent Koca, Murat Yildirim
Publikováno v:
Cancer Biomarkers. 31:409-417
BACKGROUND: Lymphocyte-to-C-reactive protein ratio (LCR) has been used as a post-surgical prognostic biomarker in patients with gastric and colorectal cancer. However, its relationship with early postoperative complications in these patients is unkno
Autor:
Junmi Lu, Guiyuan Xie, Qiuyuan Wen, Yuting Zhan, Juan Feng, Hongjing Zang, Songqing Fan, Lingjiao Chen
Publikováno v:
Cancer Biomarkers. 30:145-154
BACKGROUND: Non-small cell lung cancer (NSCLC) is one of the most widespread cancer with increasing morbidity and mortality. FAS-associated protein with death domain (FADD) is considered as an essential instrument in cell death, whereas Bcl-XS promot
Autor:
Ashraf Dallol, Jaudah Al-Maghrabi, Mohammed H. Al-Qahtani, Rawiah A. Alsiary, Abdelbaset Buhmeida, Alaa Samkari, Abeer Al-Sofyani, Jalaluddin Azam Khan, Baraa T. Alhaj-Hussain, Aisha Elaimi, Shadi S. Alkhayyat, Adel M. Abuzenadah, Ayman Khalid Johargy, Esam I. Azhar, Heba Alkhatabi, Suha A. Farraj
Publikováno v:
Cancer Biomarkers. 28:213-220
Background Oral tongue squamous cell carcinoma (OTSCC) is a highly aggressive malignancy characterized by frequent recurrence, poor survival with relatively few therapeutic options due to the late diagnosis in many cases. Objectives Understanding the
Autor:
Ching-Tung Chu, Yui Whei Chen-Yang, Chung-Kun Ho, Chia-Chi Hsieh, Hsing-Wen Lo, Jui-Chuang Wu, Vincent F.S. Tsai, Guang-Jer Wu, Yuan-Hung Pong, Yann-Rong Su
Publikováno v:
Cancer Biomarkers. 27:377-387
Background METCAM/MUC18 expression was increased with the malignant progression of prostate cancer and also a bona fide metastatic gene, capable of initiating and driving the metastasis of a non-metastatic human prostate cancer cell line to multiple
Publikováno v:
Cancer Biomarkers. 27:121-128
Background Pancreatic ductal adenocarcinoma is a devastating malignancy with an extremely poor prognosis. Although the most widely used biomarker for pancreatic cancer is carbohydrate antigen CA19-9, it is elevated mainly in the late stage of pancrea
Autor:
Pamela Di Giovanni, Federico Garbarino, Matteo Auriemma, Alessia Paganelli, Marika D'Urbano, P. Toto, Paolo Amerio, Tommaso Staniscia, Giuseppe Di Martino, Fabrizio Panarese, Roberto Paganelli
Publikováno v:
Cancer Biomarkers. 26:333-342
Background To date, serological markers to monitor melanoma progression and response to therapy are lacking. In this context cytokines appear to be promising biomarkers of the disease. Objective To compare cytokine and chemokine levels in melanoma pa
Autor:
Daley S. Morera, Jiaojiao Wang, Rohitha Baskar, Rahil Khan, Andrew Mitchell, Sarrah L. Hasanali, Charles S. Li, Asif Talukder, Daniel Albo, Roni J. Bollag, Meenakkshy Manoharan, Andre R. Jordan, Nagendra Singh, Santu Ghosh, Xin Wang, Vinata B. Lokeshwar
Publikováno v:
Cancer Biomark
BACKGROUND Differential expression of chemokines/chemokine receptors in colorectal cancer (CRC) may enable molecular characterization of patients' tumors for predicting clinical outcome. OBJECTIVE To evaluate the prognostic ability of these molecules
Publikováno v:
Cancer Biomarkers. 26:139-150
BACKGROUND No tumor biomarker (TM) is available for de novo metastatic lung adenocarcinoma. OBJECTIVE To examine the serum levels of carcinoembryonic antigen (CEA), cytokeratin-19 fragments (CYFRA21-1), neuron-specific enolase (NSE), carbohydrate ant
Publikováno v:
Cancer Biomarkers. 24:195-201
OBJECTIVE Human multiple myeloma (MM) is a kind of common tumor in middle-aged and elderly people, in which the osteolytic lesion is formed mainly through inhibiting osteoblast (OB) differentiation and promoting osteoclast (OC) differentiation. Dickk